DCGI says WHO drew premature link between children deaths in Gambia, Maiden Pharma Cough Syrups
Calling out the World Health Organisation (WHO) for "prematurely" blaming an Indian company for the deaths without verification, India's drug regulator claimed that the samples of Maiden Pharma's cough syrups suspected of being linked to deaths of children in Gambia were not contaminated glycol (DEG) and ethylene glycol (EG), and have been found to be of standard quality.
In wake of this confirmation given by the Drug Controller General of Indian (DCGI), Maiden Pharmaceuticals Ltd on Friday said that it will seek clearance to re-open its factory as the Indian government laboratory found nothing wrong in samples taken from syrups namely Promethazine Oral Solution BP, KOFEXMALIN Baby Cough Syrup, MaKOFF Baby Cough syrup and MaGrip n Cold Syrup.
For more details, check out the link given below:
DCGI Calls Out WHO For 'Prematurely' Blaming Maiden Pharma For Cough Syrup Linked Deaths In Gambia
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.